Special Issues

Special Issue Title: Human Papillomavirus and Gynaecological Oncology

· Print Special Issue Flyer

· Deadline for manuscript submissions: 30 September 2021

Special Issue Editor

Guest Editor

Associate Prof. Dr. Julio Cesar Teixeira

Department of Obstetrics and Gynecology, Faculty of Medical Sciences and Director of Oncology Division, Women’s Hospital, University of Campinas (UNICAMP), Campinas, Sao Paulo State, Brazil

Website | E-Mail

Interests: HPV; Lesions Precursors; Oncological Gynecology; Vaccines

Special Issue Information

Dear Colleagues,

The European Journal of Gynaecological Oncology planned a special issue with focuses on gynaecological cancer related to Papillomavirus (HPV) infection.

These neoplasms are an important burden of disease and predominate in specific populations, either by age, immunological condition or access to health care. The main gynecological cancer site is the uterine cervix, followed by the vulva and vagina. In general, second cancer with the highest proportion of HPV association is the cancer of the canal anal. Vaccination against the main high-risk oncogenic types is available since 2007 and has an irregular spread, with few sites reaching the necessary coverage of the primary target population, that is preadolescents or those before sexual initiation. Countries that have achieved success with high vaccine coverage in a sustained manner have already recorded a significant drop in cervical precursor lesions and now, significantly fewer cervical cancer cases.

Due to the existence of the tools to eliminate these cancers and the inequity of access, WHO is coordinating efforts in a challenging global campaign to expand vaccination coverage, screening for cervical precursor lesions, and treatment access, to achieve a significant impact by 2030. Besides, screening should progressively shift to DNA-HPV testing, crucial for the previously vaccinated population that is reaching the target age of existing programs.

Therefore, this special issue is planned for May 2021. The theme will be ‘Human Papillomavirus and Gynaecological Oncology’ and I have included the official call for papers below. If you would be able to contribute, we would be delighted to hear from you. 

Julio Cesar Teixeira MD, PhD

Guest Editor


Manuscript Submission Information

Manuscripts should be submitted online at https://ejgo.imrpress.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1250. Submitted papers should be well formatted and use good English.

Papillomavirus; HPV; HPV Vaccine; Screening; Cytology; HPV Test; Preneoplastic Lesion; CIN; VIN; VAIN; Cervical Cancer; Vaginal Cancerl Vulvar Cancerl Treatment; Survival

Share This Special Issue


Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 42, Issue 5